Executive Summary
The five contracts analyzed total $1.18 billion, with two defense-related awards (CACI and Amentum) accounting for $869 million of the aggregate, underscoring sustained DOD and GSA demand for special operations and engineering support.
The dominant theme is civilian agency spending on biodefense and healthcare services, led by a $125.5M CDC award to Icahn School of Medicine and a $92.8M BARDA delivery order to Tunnell Consulting. The highest-conviction signal is CACI’s $777M special operations support contract, which validates its competitive moat in high-priority defense niches despite cost-plus margin constraints. A key risk is the negative outlay adjustments on both the CACI and Amentum contracts, which may indicate early-stage funding timing issues or administrative delays that could pressure near-term cash flows.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior General Federal Contracts digest from June 06, 2026.
Investment Signals (4)
- CACI Wins $777M Special Operations Support Contract, Validating Defense Niche Moat (HIGH)▲
CACI NSS won a $777M cost-plus delivery order from GSA for special operations support at Fort Bragg, with options up to $1.13B. Full and open competition with no set-aside signals strong market position in a high-priority defense area.
- Amentum Secures $91.7M GSA Engineering Contract with Multi-Year Visibility (MEDIUM)▲
Amentum Services won a $91.7M delivery order (options up to $211.9M) for engineering and program management support, performed in Chantilly, VA. Full and open competition validates market position.
- BARDA Awards $92.8M Delivery Order to Tunnell Consulting for Biodefense R&D Support (MEDIUM)▲
Tunnell Consulting won a $92.8M delivery order from BARDA with options up to $660.2M through 2035 for biotech and biopharmaceutical R&D support. Signals sustained government investment in biodefense and pandemic preparedness.
- Negative Outlays on CACI and Amentum Contracts Signal Funding Timing Uncertainty (MEDIUM)▲
Both CACI ($-122K) and Amentum ($-29K) show negative outlayed amounts on their contracts, suggesting early-stage funding adjustments or payment delays that could pressure near-term cash flows.
Risk Flags (4)
- Execution [MEDIUM RISK]▼
Negative outlays on CACI ($-122K) and Amentum ($-29K) contracts indicate possible funding timing issues or administrative delays that may affect cash flow recognition.
- Concentration [HIGH RISK]▼
CACI's $777M contract represents 66% of the total aggregate value, creating single-contract concentration risk for the company's defense services segment.
- Competition [MEDIUM RISK]▼
The Icahn School of Medicine's $125.5M CDC contract has ended (2017-2022), and the re-compete for the World Trade Center Health Program Clinical Center of Excellence may shift to a different provider.
- Budget [MEDIUM RISK]▼
Tunnell Consulting's $92.8M BARDA contract has a labor-hours pricing structure, shifting cost risk to the contractor if hours exceed estimates, and the options extend to 2035, creating long-term budget uncertainty.
Opportunities (3)
- ◆
CACI's $777M special operations support contract positions the company for follow-on work in the SOF support niche, with options up to $1.13B. Monitor option exercises for additional revenue.
- ◆
Tunnell Consulting's $92.8M BARDA contract with options up to $660.2M through 2035 signals sustained government investment in biodefense and medical countermeasure R&D, creating growth opportunities for professional services firms in this niche.
- ◆
Amentum's $91.7M GSA contract with options up to $211.9M provides multi-year revenue visibility and potential for expansion into other GSA engineering support programs.
Sector Themes (3)
- ◆
CACI's $777M contract for SOF support at Fort Bragg, combined with Amentum's $91.7M engineering support, indicates continued DOD spending on high-priority special operations and program management services.
- ◆
Tunnell Consulting's $92.8M BARDA contract and Icahn School of Medicine's $125.5M CDC contract demonstrate sustained civilian agency investment in biodefense R&D and healthcare services.
- ◆
Caltech's $92.5M NASA contract for JPL high-performance spaceflight computing R&D reinforces the FFRDC model for long-term space technology development.
Watch List (4)
- 👁
{"entity"=>"CACI International Inc.", "reason"=>"$777M special operations contract represents 66% of aggregate value; option exercises and outlay resolution are critical.", "trigger"=>"Option exercise announcements; next quarterly earnings for cash flow commentary"}
- 👁
{"entity"=>"Amentum Services, Inc.", "reason"=>"$91.7M GSA contract with negative outlays; option exercise timeline and subcontractor performance are key.", "trigger"=>"Option exercise timeline; outlay direction resolution"}
- 👁
{"entity"=>"Tunnell Consulting Inc.", "reason"=>"$92.8M BARDA contract with $660.2M options; potential acquisition or IPO could create investment opportunity.", "trigger"=>"Option exercise announcements; acquisition or IPO news"}
- 👁
{"entity"=>"CDC World Trade Center Health Program", "reason"=>"Icahn School of Medicine's $125.5M contract has ended; re-compete could shift to another provider.", "trigger"=>"Follow-on contract announcements from CDC"}
Get daily alerts with 4 investment signals, 4 risk alerts, 3 opportunities and full AI analysis of all 5 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: General Federal Contracts
🇺🇸 More from United States
View all →June 12, 2026
US Pre-Market SEC Filings Roundup — June 12, 2026
US Pre-Market SEC Filings Roundup
June 12, 2026
S&P 500 Energy Sector SEC Filings — June 12, 2026
S&P 500 Energy Sector SEC Filings
June 12, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings — June 12, 2026
US Bankruptcy Chapter 11 Insolvency SEC Filings
June 12, 2026
US Executive Compensation Proxy SEC Filings — June 12, 2026
US Executive Compensation Proxy SEC Filings